Skip to content

Comparison effect of Dexamethasone on pain, nausea and vomiting and restlessness after rhinoplasty.

Investigating the effect of preventive dose of dexamethasone on pain, nausea, frequent vomiting and postoperative restlessness in patients undergoing septorhinoplasty.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240208060937N1
Enrollment
70
Registered
2024-02-18
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septorhinoplasty surgery.

Interventions

Intervention 1: Intervention group: receiving 0.1 mg/kg dexamethasone as intravenous infusion?. Intervention 2: Control group: recipient of normal saline with the same volume as the intervention group

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 55 Years

Inclusion criteria

Inclusion criteria: ASA class I and II Absence of underlying diseases including respiratory diseases, cardiovascular diseases and diabetes No long-term use of anti-nausea and vomiting drugs and corticosteroids Not smoking Electiveness of surgery Not having reflux Patient consent to participate in the study

Exclusion criteria

Exclusion criteria: Occurrence of disorder during operation that requires medical intervention Changing the operation technique or anesthesia for various reasons The impossibility of collecting data until the end of the study, including the death of the patient during the operation

Design outcomes

Primary

MeasureTime frame
Intensity of post operative pain. Timepoint: Every 6 hours after the operationuntil 24 hours. Method of measurement: Vigual Analog Scale.;Intensity of post operativenausea. Timepoint: Every 6 hours after the operation until 24 hours. Method of measurement: Vigual Analog Scale.;Restlesness after surgery. Timepoint: During recovery and every 6 hours after operation up to 24 hours. Method of measurement: Richmind scale.

Secondary

MeasureTime frame
Blood pressure. Timepoint: Every 15 minutes during operation and recovery. Method of measurement: Sphygmomanometer.;Heart bit. Timepoint: Every 15 minutes during operation and recovery. Method of measurement: Pulse oximeter made by MIVA company, Iran.;Blood oxygen saturation. Timepoint: Every 15 minutes during operation and recovery. Method of measurement: Pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed amirmohamad Taravati

Esfahan University of Medical Sciences

amir.taravati44@gmail.com+98 31 3669 2174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026